南美洲和中美洲血糖监测设备市场预测至 2030 年 - 区域分析 - 按类型(连续血糖监测设备和自我血糖监测设备)、应用(1 型糖尿病和 2 型糖尿病)、测试类型(指尖测试和备用站点测试) )和最终用户(医疗保健设置和自我/家庭护理)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 85    |    Report Code: BMIRE00029130    |    Category: Life Sciences

South & Central America Glucose Monitoring Devices Market

南部和南部中美洲血糖监测设备市场预计将从2022年的12.4506亿美元增长到2030年的27.9505亿美元。预计2022年至2030年复合年增长率为10.6%。

血糖监测设备的快速技术进步推动了南方和太平洋地区的发展。中美洲血糖监测设备市场

采用先进技术的产品为糖尿病治疗提供更有效的益处。随着全球糖尿病患病率的增加,对更多先进产品的需求也在加速。因此,研究人员多年来一直在进行研究活动,从而实现产品创新。有许多方法可以将胰岛素输送到体内,例如针头、胰岛素笔和胰岛素泵。胰岛素泵是一种小型计算机化糖尿病管理设备,与皮下插管相连,可缓慢、连续地输送胰岛素。个人可以根据需要控制程序。最佳的糖尿病管理取决于准确的血糖监测设备。血糖监测设备的不断进步导致所需血量更小,准确性也更高。血糖仪和血糖监测设备之间传输数据的能力也得到了提高。血糖监测技术的不断进步提高了准确性,减少了所需的血量,并能够在血糖仪和血糖监测设备之间传输数据。 2022 年 6 月,雅培推出了一款新型生物可穿戴设备,可通过一个传感器连续监测葡萄糖和酮水平。因此,技术进步加上新产品的不断涌入预计将在预测几年内推动市场增长。

South & South & Co.中美洲血糖监测设备市场概况

南美洲和南美洲中美洲血糖监测设备市场已细分为巴西、阿根廷以及南美其他地区和地区。中美洲。南美市场的增长中美洲因该国糖尿病人口众多而受到高度评价。由于南非糖尿病患病率很高,因此在连续血糖监测方面占有第二大份额。上述因素对南美地区血糖监测设备市场的增长具有重要影响。中美洲地区。

南美洲和南美洲地区。中美洲血糖监测设备市场收入和 2030 年预测(百万美元)

South &中美洲血糖监测设备市场细分

南美洲和南美洲中美洲血糖监测设备市场按类型、应用、测试地点、最终用户和国家/地区进行细分。

根据类型,南部和地区分为不同类型。中美洲血糖监测设备市场分为连续血糖监测设备和自我血糖监测设备。连续血糖监测设备领域在南美和南美占据较大份额。 2022 年中美洲血糖监测设备市场。中美洲血糖监测设备市场分为 1 型糖尿病和 2 型糖尿病。 2 型糖尿病在南美两国所占比例较大。 2022 年中美洲血糖监测设备市场。

根据测试网站,South &中美洲血糖监测设备市场分为指尖测试和备用站点测试。指尖测试部分在南美和南美占据了更大的份额。 2022 年中美洲血糖监测设备市场。

根据最终用户,南美洲和南美洲中美洲血糖监测设备市场分为医疗保健环境和自我/家庭护理。自我/家庭护理部分在南部和南部地区占有较大份额。 2022 年中美洲血糖监测设备市场。

按国家/地区划分,南美洲和南美洲中美洲血糖监测设备市场分为巴西、阿根廷和南美洲其他地区。中美洲。巴西在南部和南部地区占据主导地位。 2022 年中美洲血糖监测设备市场。

B.  Braun SE、F. Hoffmann-La Roche Ltd、Medtronic Plc、Abbott Laboratories、Ypsomed Holding AG 和 GE HealthCare Technologies Inc 是在南部和南部地区运营的一些领先公司。中美洲血糖监测设备市场。   



South & Central America Glucose Monitoring Devices Strategic Insights

Strategic insights for South & Central America Glucose Monitoring Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-glucose-monitoring-devices-market-strategic-framework.webp
Get more information on this report

South & Central America Glucose Monitoring Devices Report Scope

Report Attribute Details
Market size in 2022 US$ 1,245.06 Million
Market Size by 2030 US$ 2,795.05 Million
Global CAGR (2022 - 2030) 10.6%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 类型
  • 连续血糖监测设备
  • 自我血糖监测设备
By 应用
  • 1 型糖尿病
  • 2 型糖尿病
By 测试类型
  • 指尖测试
  • 替代站点测试
By 最终用户
  • 医疗机构
  • 自我/家庭护理
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • GE HealthCare Technologies Inc
  • Get more information on this report

    South & Central America Glucose Monitoring Devices Regional Insights

    The regional scope of South & Central America Glucose Monitoring Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-glucose-monitoring-devices-market-geography.webp
    Get more information on this report

    The List of Companies - South & Central America Glucose Monitoring Devices Market

    • B. Braun SE
    • F. Hoffmann-La Roche Ltd
    • Medtronic Plc
    • Abbott Laboratories
    • Ypsomed Holding AG
    • GE HealthCare Technologies Inc
    Frequently Asked Questions
    How big is the South & Central America Glucose Monitoring Devices Market?

    The South & Central America Glucose Monitoring Devices Market is valued at US$ 1,245.06 Million in 2022, it is projected to reach US$ 2,795.05 Million by 2030.

    What is the CAGR for South & Central America Glucose Monitoring Devices Market by (2022 - 2030)?

    As per our report South & Central America Glucose Monitoring Devices Market, the market size is valued at US$ 1,245.06 Million in 2022, projecting it to reach US$ 2,795.05 Million by 2030. This translates to a CAGR of approximately 10.6% during the forecast period.

    What segments are covered in this report?

    The South & Central America Glucose Monitoring Devices Market report typically cover these key segments-

  • 类型 (连续血糖监测设备, 自我血糖监测设备)
  • 应用 (1 型糖尿病, 2 型糖尿病)
  • 测试类型 (指尖测试, 替代站点测试)
  • What is the historic period, base year, and forecast period taken for South & Central America Glucose Monitoring Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Glucose Monitoring Devices Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Glucose Monitoring Devices Market?

    The South & Central America Glucose Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • GE HealthCare Technologies Inc
  • Who should buy this report?

    The South & Central America Glucose Monitoring Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Glucose Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.